Graham F Pineo1, Russell D Hull. Show Affiliations » 1. University of Calgary, South Tower Foothills Hospital, Unit 1633, 1632 - 14th AVE NW, Calgary, Alberta, T2N 1M7, Canada. graham.pineo@calgaryhealthregion.ca
Abstract
Entities: Chemical Disease
Mesh： See more » Anticoagulants/pharmacologyAnticoagulants/therapeutic useAntineoplastic Agents/therapeutic useBlood Coagulation Factors/physiologyClinical Trials as TopicDisease ProgressionGlucuronidase/physiologyHeparin/pharmacologyHeparin/therapeutic useHeparin, Low-Molecular-Weight/therapeutic useHumansNeoplasm MetastasisNeoplasms/bloodNeoplasms/complicationsNeoplasms/drug therapyNeoplasms/pathologyNeovascularization, Pathologic/drug therapyNeovascularization, Pathologic/etiologyNeovascularization, Pathologic/physiopathologySelectins/physiologyThrombin/antagonists & inhibitorsThromboembolism/etiologyThromboembolism/prevention & controlThrombophilia/etiologyThromboplastin/physiology
Substances： See more » AnticoagulantsAntineoplastic AgentsBlood Coagulation FactorsHeparin, Low-Molecular-WeightSelectinsHeparinThromboplastinheparanaseGlucuronidaseThrombin
Year: 2009 PMID： 19377929 DOI： 10.1007/978-0-387-79962-9_15
Source DB: PubMed Journal: Cancer Treat Res ISSN： 0927-3042